These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22976313)

  • 1. Hepatogenous diabetes in cirrhosis: academic sport or a neglected disease?
    Gundling F; Schepp W; Schumm-Draeger PM
    Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):469-71. PubMed ID: 22976313
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential diagnosis of diabetes mellitus caused by liver cirrhosis and other type 2 diabetes mellitus].
    Kim MG; Choi WC
    Korean J Hepatol; 2006 Dec; 12(4):524-9. PubMed ID: 17237630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of hepatogenous diabetes in liver cirrhosis.
    Holstein A; Hinze S; Thiessen E; Plaschke A; Egberts EH
    J Gastroenterol Hepatol; 2002 Jun; 17(6):677-81. PubMed ID: 12100613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatogenous diabetes - diagnostics and treatment].
    Gundling F; Schumm-Draeger PM; Schepp W
    Z Gastroenterol; 2009 May; 47(5):436-45. PubMed ID: 19418413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal glucose tolerance in cystic fibrosis: why should patients be screened?
    Moran A; Milla C
    J Pediatr; 2003 Feb; 142(2):97-9. PubMed ID: 12584525
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?
    Orsi E; Grancini V; Menini S; Aghemo A; Pugliese G
    Liver Int; 2017 Jul; 37(7):950-962. PubMed ID: 27943508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common complications of cirrhosis: do we follow too often the 'Casablanca strategy'?
    Gundling F; Schmidt T; Schepp W
    Liver Int; 2011 Nov; 31(10):1598-600. PubMed ID: 21745306
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolic disturbances in liver cirrhosis (part 2), hepatogenous diabetes: diagnostic aspects and treatment].
    Gundling F; Seidl H; Löffler N; Strassen I; Schepp W
    Dtsch Med Wochenschr; 2010 Jan; 135(1-2):22-4. PubMed ID: 20024879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatogenous diabetes. Current views of an ancient problem.
    García-Compean D; Jaquez-Quintana JO; Maldonado-Garza H
    Ann Hepatol; 2009; 8(1):13-20. PubMed ID: 19221528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and prevalence of latent hepatic encephalopathy].
    Koch H; Schauder P; Schäfer G; Dahme B; Ebel W; Vahldiek B; König F; Henning H
    Z Gastroenterol; 1990 Nov; 28(11):610-5. PubMed ID: 2288139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease.
    Manchanayake J; Chitturi S; Nolan C; Farrell GC
    J Gastroenterol Hepatol; 2011 Mar; 26(3):510-6. PubMed ID: 21155882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research on prognosis of liver cirrhosis patients with hepatitis B virus infection superimposed on alcoholic liver disease].
    Xiang GQ; Meng XD; He XH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):72-3. PubMed ID: 19203461
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatogenic diabetes: pathophysiology, therapeutic options and prognosis].
    Petrides AS
    Z Gastroenterol; 1999 Jun; Suppl 1():15-21. PubMed ID: 10444811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining prevalence of diabetes mellitus in hereditary haemochromatosis--the result of earlier diagnosis.
    O'Sullivan EP; McDermott JH; Murphy MS; Sen S; Walsh CH
    Diabetes Res Clin Pract; 2008 Sep; 81(3):316-20. PubMed ID: 18565609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic encephalopathy forward to the past.
    Blendis L
    Gastroenterology; 2006 Jun; 130(7):2239-40. PubMed ID: 16762648
    [No Abstract]   [Full Text] [Related]  

  • 16. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis.
    Kalaitzakis E; Olsson R; Henfridsson P; Hugosson I; Bengtsson M; Jalan R; Björnsson E
    Liver Int; 2007 Nov; 27(9):1194-201. PubMed ID: 17919230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should all patients with nonalcoholic fatty liver disease undergo oral glucose tolerance test?
    Wong VW; Chan HL
    J Gastroenterol Hepatol; 2011 Mar; 26(3):419-20. PubMed ID: 21332536
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver disease, insulin antagonism and diabetes mellitus.
    Creutzfeldt W; Frerichs H; Kneer P
    Horm Metab Res; 1974; Suppl 4():135-42. PubMed ID: 4423508
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis of diabetes in cystic fibrosis and thalassemia major.
    Holl RW; Buck C; Cario H; Wolf A; Thon A; Kohne E; Debatin KM
    Diabetes Care; 1998 Apr; 21(4):671-2. PubMed ID: 9571365
    [No Abstract]   [Full Text] [Related]  

  • 20. Higher prevalence and severity of hepatic encephalopathy in patients with HCV cirrhosis and diabetes mellitus: is presence of autonomic neuropathy the missing part of the puzzle?
    Thuluvath PJ
    Am J Gastroenterol; 2006 Oct; 101(10):2244-6. PubMed ID: 17032188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.